Lines of management differ according to the disease type; in T1D and as the exogenous insulin replacement did not achieve the optimum metabolic regulation, new technologies have emerged in addition to different insulin analogues (insulin pump and continuous glucose monitoring), which has contributed to improving the control of T1D over the last decades. Here, INS is linked to type 1 diabetes mellitus.